Literature DB >> 23494777

Zap70 inhibits Syk-mediated osteoclast function.

Wei Zou1, Monica Croke, Tomohiro Fukunaga, Thomas J Broekelmann, Robert P Mecham, Steven L Teitelbaum.   

Abstract

The αvβ3 integrin stimulates the resorptive capacity of the differentiated osteoclast (OC) by organizing its cytoskeleton via the tyrosine kinase, Syk. Thus, Syk-deficient OCs fails to spread or form actin rings, in vitro and in vivo. The Syk family of tyrosine kinases consists of Syk itself and Zap70 which are expressed by different cell types. Because of their structural similarity, and its compensatory properties in other cells, we asked if Zap70 can substitute for absence of Syk in OCs. While expression of Syk, as expected, normalizes the cytoskeletal abnormalities of Syk(-/-) OCs, Zap70 fails do so. In keeping with this observation, Syk, but not Zap70, rescues αvβ3 integrin-induced SLP76 phosphorylation in Syk(-/-) OCs. Furthermore the kinase sequence of Syk partially rescues the Syk(-/-) phenotype but full normalization also requires its SH2 domains. Surprisingly, expression of Zap70 inhibits WT OC spreading, actin ring formation and bone resorptive activity, but not differentiation. In keeping with arrested cytoskeletal organization, Zap70 blocks integrin-activated endogenous Syk and Vav3, SLP76 phosphorylation. Such inhibition requires Zap70 kinase activity, as it is abolished by mutation of the Zap70 kinase domain. Thus, while the kinase domain of Syk is uniquely required for OC function that of Zap70 inhibits it.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23494777      PMCID: PMC3977572          DOI: 10.1002/jcb.24531

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  29 in total

Review 1.  Osteoclast differentiation and activation.

Authors:  William J Boyle; W Scott Simonet; David L Lacey
Journal:  Nature       Date:  2003-05-15       Impact factor: 49.962

2.  Rac deletion in osteoclasts causes severe osteopetrosis.

Authors:  Monica Croke; F Patrick Ross; Matti Korhonen; David A Williams; Wei Zou; Steven L Teitelbaum
Journal:  J Cell Sci       Date:  2011-11-23       Impact factor: 5.285

3.  Reconstitution of Syk function by the ZAP-70 protein tyrosine kinase.

Authors:  G H Kong; J Y Bu; T Kurosaki; A S Shaw; A C Chan
Journal:  Immunity       Date:  1995-05       Impact factor: 31.745

Review 4.  The Syk/ZAP-70 protein tyrosine kinase connection to antigen receptor signalling processes.

Authors:  N S van Oers; A Weiss
Journal:  Semin Immunol       Date:  1995-08       Impact factor: 11.130

5.  TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand.

Authors:  J Lam; S Takeshita; J E Barker; O Kanagawa; F P Ross; S L Teitelbaum
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

6.  Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk.

Authors:  M Turner; P J Mee; P S Costello; O Williams; A A Price; L P Duddy; M T Furlong; R L Geahlen; V L Tybulewicz
Journal:  Nature       Date:  1995-11-16       Impact factor: 49.962

7.  T cell activation by clustered tyrosine kinases.

Authors:  W Kolanus; C Romeo; B Seed
Journal:  Cell       Date:  1993-07-16       Impact factor: 41.582

8.  High dose M-CSF partially rescues the Dap12-/- osteoclast phenotype.

Authors:  Roberta Faccio; Wei Zou; Graziana Colaianni; Steven L Teitelbaum; F Patrick Ross
Journal:  J Cell Biochem       Date:  2003-12-01       Impact factor: 4.429

9.  Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice.

Authors:  P Soriano; C Montgomery; R Geske; A Bradley
Journal:  Cell       Date:  1991-02-22       Impact factor: 41.582

10.  Tyrosine kinases Lyn and Syk regulate B cell receptor-coupled Ca2+ mobilization through distinct pathways.

Authors:  M Takata; H Sabe; A Hata; T Inazu; Y Homma; T Nukada; H Yamamura; T Kurosaki
Journal:  EMBO J       Date:  1994-03-15       Impact factor: 11.598

View more
  7 in total

1.  γδTCR recruits the Syk/PI3K axis to drive proinflammatory differentiation program.

Authors:  Ryunosuke Muro; Takeshi Nitta; Kenta Nakano; Tadashi Okamura; Hiroshi Takayanagi; Harumi Suzuki
Journal:  J Clin Invest       Date:  2017-12-04       Impact factor: 14.808

2.  Vinculin regulates osteoclast function.

Authors:  Tomohiro Fukunaga; Wei Zou; Julia T Warren; Steven L Teitelbaum
Journal:  J Biol Chem       Date:  2014-03-27       Impact factor: 5.157

Review 3.  Osteoclasts-Key Players in Skeletal Health and Disease.

Authors:  Deborah Veis Novack; Gabriel Mbalaviele
Journal:  Microbiol Spectr       Date:  2016-06

4.  Inhibition of osteoclast activation by phloretin through disturbing αvβ3 integrin-c-Src pathway.

Authors:  Eun-Jung Lee; Jung-Lye Kim; Ju-Hyun Gong; Sin-Hye Park; Young-Hee Kang
Journal:  Biomed Res Int       Date:  2015-03-05       Impact factor: 3.411

5.  Hematopoietic or Osteoclast-Specific Deletion of Syk Leads to Increased Bone Mass in Experimental Mice.

Authors:  Dániel Csete; Edina Simon; Ahmad Alatshan; Petra Aradi; Csaba Dobó-Nagy; Zoltán Jakus; Szilvia Benkő; Dávid S Győri; Attila Mócsai
Journal:  Front Immunol       Date:  2019-04-30       Impact factor: 7.561

Review 6.  Overview of RAW264.7 for osteoclastogensis study: Phenotype and stimuli.

Authors:  Lingbo Kong; Wanli Smith; Dingjun Hao
Journal:  J Cell Mol Med       Date:  2019-03-20       Impact factor: 5.310

7.  ThPOK Inhibits Osteoclast Formation Via NFATc1 Transcription and Function.

Authors:  Wei Zou; Takashi Izawa; Nidhi Rohatgi; Steven Y Zou; Yongjia Li; Steven L Teitelbaum
Journal:  JBMR Plus       Date:  2022-03-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.